Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

22.0K
The lymphodepletive and immunomodulatory effects of chemotherapy and radiation standard of care can be leveraged to enhance the antitumor efficacy of T cell immunotherapy. We outline a method for generating EGFRvIII-specific chimeric antigen receptor (CAR) T cells and administering them in the context of glioblastoma standard of care.
22.0K
The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

9.5K
The combined use of transcranial direct current stimulation and robotic therapy as an add-on for conventional rehabilitation therapy may result in improved therapeutic outcomes due to modulation of brain plasticity. In this article, we describe the combined methods used in our institute for improving motor performance after...
9.5K
Future Value01:11

Future Value

776
The future value (FV) concept is fundamental in finance as it reflects the time value of money. It shows how a current sum of money will grow over time at a specific interest rate. This principle helps investors understand potential investment growth, making it easier to compare different financial options.
Understanding future value offers several benefits. For example, it helps in making informed investment decisions. By projecting investment growth, individuals can compare financial products...
776
A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible10:42

A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible

6.9K
Here, we propose a practical, feasible and reproducible evaluation guideline for computer-assisted reconstruction of the mandible in order to create uniformity between studies regarding postoperative accuracy evaluation. This protocol continues and specifies an earlier publication of this evaluation...
6.9K
Guidelines in Case of a Laboratory Emergency05:28

Guidelines in Case of a Laboratory Emergency

198.8K
Robert M. Rioux & Zhifeng Chen, Pennsylvania State University, University Park, PA
The most common laboratory emergencies include chemical spills, fire or explosion, electric shock, and personnel injuries. Most laboratory accidents occur due to poor planning or lack of attention. Therefore, it's always better to prevent accidents (being proactive) than having to take any actions during an emergency (being reactive). For example, always wear proper personal protective equipment (PPE) in the...
198.8K
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

755
The therapeutic application of extracellular vesicles (EVs) has the potential to revolutionize cancer treatment and drug delivery. Chimeric antigen receptor (CAR) cell-derived EVs (CAR-EVs) isolated using ion-exchange chromatography exhibit increased cargo capacity, significantly enhancing their functional efficacy. This study further characterizes CAR-EVs to elucidate their biological activity and therapeutic...
755

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Associated With Pre-donation Health-related Quality-of-Life Among Pediatric Sibling Hematopoietic Cell Donors: A DonorKids QL Study.

Transplantation and cellular therapy·2026
Same author

RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report.

American journal of hematology·2026
Same author

Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research Analysis.

Transplantation and cellular therapy·2025
Same author

Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantation.

Blood·2025
Same author

Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort.

Transplantation and cellular therapy·2025
Same author

An Open-Source Normothermic Perfusion System Designed for Research Scientists.

Journal of visualized experiments : JoVE·2025
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jan 20, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.0K

Current and Future Cell Therapy Standards and Guidelines.

J Wade Atkins1, Kamille West2, Kimberly A Kasow3

  • 1Department of Transfusion Medicine, Clinical Center, NIH, 10 Center Drive, MSC-1184, Building 10, Room 1C/711B, Bethesda, MD 20892-1184, USA.

Hematology/Oncology Clinics of North America
|August 31, 2019
PubMed
Summary
This summary is machine-generated.

Human cell-based biologics offer therapeutic potential but carry risks from manipulation. Collaboration and regulatory advancements like the 21st Century Cures Act are crucial for safe clinical development and patient access.

Keywords:
Biologic drug productsCellular therapiesHCT/PsLicensure requirementsPHS 351 and 361

More Related Videos

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

Published on: September 23, 2018

9.5K
A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible
10:42

A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible

Published on: January 28, 2020

6.9K

Related Experiment Videos

Last Updated: Jan 20, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.0K
The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

Published on: September 23, 2018

9.5K
A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible
10:42

A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible

Published on: January 28, 2020

6.9K

Area of Science:

  • Cell biology
  • Biotechnology
  • Clinical medicine

Background:

  • Cell-derived products as biologics are rapidly advancing.
  • Human cell-based products show great potential for treating serious conditions.
  • Potential unidentified risks exist with these advanced therapies.

Purpose of the Study:

  • To highlight the collaborative efforts in developing cell-based biologics.
  • To discuss the risks and regulatory landscape of cell-based drug development.
  • To emphasize the importance of interdisciplinary collaboration for safe clinical implementation.

Main Methods:

  • Review of current trends in cell biology and cellular engineering for drug development.
  • Analysis of the impact of manipulations, expansions, and gene modifications on product safety.
  • Examination of the regulatory pathways, including the 21st Century Cures Act, for accelerated approvals.

Main Results:

  • Cell-derived biologics represent a rapidly advancing field with significant therapeutic promise.
  • Product risks can be increased by in vitro manipulations and genetic modifications.
  • The 21st Century Cures Act facilitates expedited clinical trials and licensure.

Conclusions:

  • Collaboration among researchers, engineers, clinicians, regulators, and industry is essential.
  • Safe development and implementation of cell-based therapies require careful risk assessment.
  • Interdisciplinary teamwork is key to meeting the needs of critically ill patients with novel biologics.